Montana Chapter of the American College of Cardiology

Interventional Post-ACS Antithrombotic Trials at ESC Congress 2026
Four late-breaking trials, presented at ESC Congress 2026 focused on post-acute coronary syndrome (ACS) antithrombotic therapy.
Sports Cardiology Research and Guideline Highlights: Early 2026
The 2026 ESC/ACC clinical consensus statement on Masters Athletes With Abnormal Cardiovascular Findings is guided by a clinical consensus statement outlining expert recommendations for the diagnostic assessment, management, and risk stratification of cardiac abnormalities in masters athletes (MAs).
Structural Heart Disease Trials Featured at ESC Congress 2026
Four late-breaking trials presented at ESC Congress 2026 offer new insights into the management of structural heart disease and heart failure (HF).
ACC Scientific Statement Calls For Exercise Prescription as Key Element of Routine CV Care
Exercise should be prescribed as a foundational component of routine cardiovascular care, according to a new ACC Scientific Statement on Exercise Prescriptions for Cardiovascular Health in Adults. Read the full statement in JACC.
Clinical Algorithm For the Follow-Up of Aortic Valve Disease
The incidence of valvular aortic stenosis (AS) is estimated to be 0.2-0.4 per 1,000 live births. Bicuspid aortic valve (BAV) is the most common cause of AS and one of the most common types of congenital heart disease, with an incidence estimated by autopsy studies of approximately 1%.